Previous Close | 15.50 |
Open | 15.50 |
Bid | 14.60 x 301800 |
Ask | 15.45 x 45100 |
Day's Range | 15.50 - 15.50 |
52 Week Range | 10.80 - 15.70 |
Volume | |
Avg. Volume | 1,393 |
Market Cap | 13.219B |
Beta (5Y Monthly) | 0.62 |
PE Ratio (TTM) | 43.31 |
EPS (TTM) | 0.35 |
Earnings Date | Aug 01, 2024 |
Forward Dividend & Yield | 0.38 (2.47%) |
Ex-Dividend Date | Oct 03, 2024 |
1y Target Est | N/A |
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company announced today that its LEGION Hinged Knee (HK) System is now available in the United States with proprietary OXINIUM (Oxidized Zirconium) implant technology that delivers the durability of metals, the wear resistance of ceramics, and corrosion resistance better than both.1-11 Part of the LEGION Total Knee (TK) System, the LEGION HK System is designed to provide a natural range of motion with medial pivot, lateral roll back,
Smith & Nephew (LSE:SN.) is navigating a dynamic environment marked by both opportunities and challenges. Recent highlights include a notable 5.6% revenue growth and innovative product launches, juxtaposed against a high Price-To-Earnings Ratio and concerns about dividend sustainability. In the discussion that follows, we will delve into Smith & Nephew's financial health, operational inefficiencies, strategic growth initiatives, and external threats to provide a comprehensive overview of the...
The United Kingdom's stock market has been facing headwinds, with the FTSE 100 index closing lower due to weak trade data from China and a faltering global economy. Despite these challenges, value investing remains a viable strategy for discerning investors seeking opportunities in undervalued stocks.